NCT02140125View on ClinicalTrials.gov

A Study to Evaluate the Safety of ASP2408 After Subcutaneous Administration to Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions
HealthyPharmacokinetics of ASP2408
Interventions
DRUG

ASP2408

subcutaneous administration

DRUG

Placebo

subcutaneous administration

Trial Locations (1)

Unknown

Kyushu

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY